Chodosh James

Long-term Visual Outcomes and Complications of Boston Keratoprosthesis Type II Implantation.

The Boston keratoprosthesis type II is a viable option to salvage vision in patients with poor prognosis for other corneal procedures.

Chemical Burns of the Eye: The Role of Retinal Injury and New Therapeutic Possibilities.

A new regimen, in addition to standard treatment, for severe chemical burns is proposed.

Design and Outcomes of a Novel Keratoprosthesis: Addressing Unmet Needs in End-Stage Cicatricial Corneal Blindness.

The Lux keratoprosthesis was developed for patients with severe cicatricial keratoconjunctivitis who were otherwise not candidates for existing keratoprosthesis designs. Short-term outcomes after implantation of the Lux keratoprosthesis were encouraging.

Glaucoma Management in Patients With Aniridia and Boston Type 1 Keratoprosthesis.

Despite a higher glaucoma prevalence, eyes with aniridia achieved similar VA as comparison eyes with more than 5 years of mean follow-up time.

Restoration of Vision in Severe, Cicatricial, Ocular Surface Disease With the Boston Keratoprosthesis Type II.

Advances in device design and postoperative care have made implantation of BK2 a viable option for corneal blindness in the setting of severe cicatricial OSD.

Three-Dimensional Optical Coherence Tomography Imaging For Glaucoma Associated With Boston Keratoprosthesis Type I and II.

Spectral domain OCT volume scans offer the possibility to enhance the evaluation of KPro patients with glaucoma by using both 2D and 3D diagnostic parameters that are easily obtained in a clinic setting.

The prophylactic value of TNF-α inhibitors against retinal cell apoptosis and optic nerve axon loss after corneal surgery or trauma.

Subconjunctival injection of 4.0 mg adalimumab in rabbits shows no eye toxicity and provides excellent neuroprotection, both short (3 days) and long-term (90 days).

Angle Anatomy and Glaucoma in Patients With Boston Keratoprosthesis.

The temporal angle was the most visible on AS-OCT in eyes with a KPro. Significant narrowing of the temporal angle detected on AS-OCT was associated with glaucoma in these eyes.

The Prevalence of Autoimmune Diseases in Patients with Primary Open-Angle Glaucoma Undergoing Ophthalmic Surgeries.

A higher prevalence of AiD was found in POAG patients compared with control patients undergoing ophthalmic surgery.

A Patient With Glaucoma With Corneal Edema.

Results of Lucia Keratoprosthesis Implantation in Severe Corneal Disease.

The Lucia KPro offers functional success in severe corneal diseases and excellent retention in the short to intermediate term.

Endoscopic Cyclophotocoagulation for the Treatment of Glaucoma in Boston Keratoprosthesis Type II Patient.

We describe the surgical technique of endoscopic cyclophotocoagulation in a Boston keratoprosthesis type II patient. This patient with ocular cicatricial pemphigoid had pars plana endoscopic cyclophotocoagula through wounds created in the eyelids.

Glaucoma in Patients With Endothelial Keratoplasty.

In addition, we summarize the studies assessing graft outcomes in EK patients with glaucoma or glaucoma surgery. Finally, we provide future directions to improve clinical care in EK patients with glaucoma.

Artifacts in OCT Retinal Nerve Fiber Layer Imaging in Patients with Boston Keratoprosthesis Type 1.

The rate of OCT RNFL images with either poor signal strength or artifacts in the KPro and control population was comparable.

Short-Term Outcomes of Modified Boston Type-II Keratoprosthesis Implantation With Autologous Auricular Cartilage Reinforcement.

The modified AACR-BK2 procedure could be considered to restore vision in patients with end-stage corneal blindness.

Optical Coherence Tomography Angiography in Patients With the Boston Keratoprosthesis Type 1.

This is the first study assessing OCTA in KPro patients and identified a higher incidence of artifacts that may be associated with the KPro optic.

Surveillance Tools Emerging From Search Engines and Social Media Data for Determining Eye Disease Patterns.

Internet-based search engine and social media data may reflect the occurrence of clinically diagnosed conjunctivitis, suggesting that these data sources can be leveraged to better understand the epidemiologic factors of conjunctivitis.

Primary implantation of type I Boston keratoprosthesis in nonautoimmune corneal diseases.

In a large series with long follow-up, primary Boston KPro effectively restored vision. Close follow-up is needed to manage the known complications after Boston KPro.